Skip to main content

Table 3 Multivariate analysis of total CD63 score and total TIMP-1 score

From: Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

 

Baseline model

CD63

 

Patients (n)

HR (95% CI)

P-value

HR (95% CI)

P-value

Age (continuous)

74

1.01 (0.98–1.03)

0.70

1.00 (0.98–1.03)

0.71

Sex

 Male

47

1.00

 

1.00

 

 Female

27

0.82 (0.49–1.37)

0.44

0.76 (0.45–1.29)

0.31

TIMP-1 score

 0–5

12

1.00

 

1.00

 

 6–7

26

5.05 (2.14–11.9)

< 0.001

5.06 (2.13–12.0)

< 0.001

 8–9

24

3.33 (1.43–7.71)

0.005

3.27 (1.38–7.76)

0.007

 10–12

12

5.18 (1.96–13.6)

0.001

4.66 (1.74–12.5)

0.002

CD63 score

 0–6

22

–

–

1.00

 

 7–8

29

–

–

1.09 (0.58–2.06)

0.79

 9–12

23

–

–

1.51 (0.78–2.91)

0.22